MC
Murahari Chinthirla
About Murahari Chinthirla
Data last updated:
Murahari Chinthirla has 15 years in corporate governance. Holds Whole-Time Director role. Currently with 1 company, including Elite Multi Speciality Hospital Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Elite Multi Speciality Hospital Private Limited at ₹13.63 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 27 Apr 2011 | 2011 | ₹13.63 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Murahari Chinthirla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Murahari Chinthirla
Murahari Chinthirla has 15 years in corporate governance. Holds Whole-Time Director role. Currently with 1 company, including Elite Multi Speciality Hospital Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Elite Multi Speciality Hospital Private Limited at ₹13.63 Cr (FY 2024).
Murahari Chinthirla is associated with 1 company as Whole-Time Director, including Elite Multi Speciality Hospital Private Limited (₹13.63 Cr).
Murahari Chinthirla has expertise in General Business.
Murahari Chinthirla has 15 years in corporate governance.
By reported revenue, the largest current company of Murahari Chinthirla is Elite Multi Speciality Hospital Private Limited, with revenue of ₹13.63 Cr (FY 2024).
Murahari Chinthirla currently holds positions at 1 company: Elite Multi Speciality Hospital Private Limited (₹13.63 Cr).